SCHEMBL4600346

SCHEMBL4600346

COc1ccc(CNc2[c]ccc(OS(C)(=O)=O)c2)c(OC)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.48
TP53 P04637 1/20 0.45
ERBB2 P04626 1/20 0.42
PRKACA P17612 1/20 0.42
RPS6KB1 P23443 1/20 0.42
GSK3A P49840 1/20 0.42
GSK3B P49841 1/20 0.42
IRAK1 P51617 1/20 0.42
RPS6KA3 P51812 1/20 0.42
ROCK1 Q13464 1/20 0.42
CDC42BPA Q5VT25 1/20 0.42
AURKB Q96GD4 1/20 0.42
CSNK1G3 Q9Y6M4 1/20 0.42
CYP1A2 P05177 7/20 0.41
CYP3A4 P08684 7/20 0.41
CYP2D6 P10635 7/20 0.41
CYP2C19 P33261 7/20 0.41
USP2 O75604 5/20 0.41
CYP2C9 P11712 5/20 0.41
MAPK1 P28482 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4610582 0.86 ALDH1A1 (0.45) APLNRTP53CYP1A2CYP3A4CYP2D6
SCHEMBL4599436 0.79 APLNR (0.54) APLNRTP53ERBB2PRKACARPS6KB1
SCHEMBL4599467 0.79 APLNR (0.54) APLNRTP53ERBB2PRKACARPS6KB1
SCHEMBL4599690 0.79 APLNR (0.54) APLNRERBB2PRKACARPS6KB1GSK3A
SCHEMBL4599421 0.77 MAOB (0.50) APLNRCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL4599680 0.77 MAPT (0.52) APLNRERBB2PRKACARPS6KB1GSK3A
SCHEMBL4599588 0.76 KDM4E (0.37) ALDH1A1LMNA
SCHEMBL4599391 0.75 HTT (0.40) ALDH1A1LMNA
SCHEMBL28975506 0.71 CYP1A2 (0.59) APLNRTP53CYP1A2CYP3A4CYP2D6
SCHEMBL1530735 0.71 APLNR (0.65) APLNRTP53CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed